These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17164754)

  • 1. Endothelin-1, platelets and Raynaud's phenomenon.
    Gazi I; Jagroop IA; Mikhailidis DP
    Int Angiol; 2006 Dec; 25(4):436. PubMed ID: 17164754
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endothelin-1 in pathogenesis of Raynaud's syndrome].
    Knapik-Kordecka M; Adamiec R; Ciosek W
    Pol Merkur Lekarski; 2001 Jun; 10(60):424-5. PubMed ID: 11503255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 and cold provocation in health, primary Raynaud's phenomenon, and progressive systemic sclerosis.
    Dörffler-Melly J; Lüscher TF; Wenk M; Wen S; Bollinger A; Franzeck UK
    Microvasc Res; 1996 Sep; 52(2):193-7. PubMed ID: 8901448
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aetiology of Raynaud's phenomenon.
    Turton EP; Kent PJ; Kester RC
    Cardiovasc Surg; 1998 Oct; 6(5):431-40. PubMed ID: 9794259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Raynaud's phenomenon: still current clinical problem].
    Rychlik-Golema W; Adamiec R; Bednarska-Chabowska D; Adamiec J
    Przegl Lek; 2002; 59(1):49-54. PubMed ID: 12108048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma endothelin levels in patients with Raynaud's phenomenon.
    Biondi ML; Marasini B; Bassani C; Agastoni A
    N Engl J Med; 1991 Apr; 324(16):1139-40. PubMed ID: 2008192
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenoceptors on blood cells from patients with primary Raynaud's phenomenon.
    Jeremy JY; Gill J; Barradas MA; Mikhailidis DP
    Clin Sci (Lond); 1991 Sep; 81(3):447. PubMed ID: 1655348
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raynaud's phenomenon: pathogenesis and management.
    Bakst R; Merola JF; Franks AG; Sanchez M
    J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
    Henness S; Wigley FM
    Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anorexia nervosa and Raynaud's phenomenon: a case report.
    Yucel B; Uzum AK; Ozbey N; Kamali S; Yager J
    Int J Eat Disord; 2007 Dec; 40(8):762-5. PubMed ID: 17607716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raynaud's phenomenon, histamine, and prostaglandins.
    Horrobin DF; Jenkins K; Manku MS
    Lancet; 1983 Sep; 2(8352):747-8. PubMed ID: 6136879
    [No Abstract]   [Full Text] [Related]  

  • 14. [The plasma endothelin concentration during cold provocation in Raynaud's syndrome].
    Koch HJ
    Dtsch Med Wochenschr; 1995 Nov; 120(45):1569. PubMed ID: 7588036
    [No Abstract]   [Full Text] [Related]  

  • 15. [Temperature-dependent rheological changes of the plasma in Raynaud's phenomenon (author's transl)].
    Kono I; Kabashima T; Yamane K; Sakurai T; Kashiwagi H; Ohshima N
    Ryumachi; 1982 Apr; 22(2):125-8. PubMed ID: 7112286
    [No Abstract]   [Full Text] [Related]  

  • 16. von Willebrand factor activity in primary and in scleroderma-associated Raynaud's phenomenon.
    Cuenca R; Fernadez-Cortijo J; Fonollosa V; Lima J; Simeon CP; Vilardell M; Pico M
    Lancet; 1990 May; 335(8697):1095. PubMed ID: 1970389
    [No Abstract]   [Full Text] [Related]  

  • 17. An unusual association with Raynaud's phenomenon.
    Binymin KA
    Rheumatology (Oxford); 2007 May; 46(5):894; author reply 894. PubMed ID: 17384174
    [No Abstract]   [Full Text] [Related]  

  • 18. Endothelin and Raynaud's phenomenon.
    Kanno K; Hirata Y; Emori T; Ohta K; Shichiri M; Shinohara S; Chida Y; Tomura S; Marumo F
    Am J Med; 1991 Jan; 90(1):130-2. PubMed ID: 1986582
    [No Abstract]   [Full Text] [Related]  

  • 19. [Physiopathology of Raynaud phenomenon: current data].
    Mourad JJ; Priollet P
    Rev Med Interne; 1997; 18(8):611-7. PubMed ID: 9365735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raynaud's phenomenon associated with Kimura's disease.
    Green SE; Linton SM; Harding JR; Attanoos R
    Rheumatology (Oxford); 2005 Apr; 44(4):559-61. PubMed ID: 15613401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.